Subscribe to Newsletter

Rob Coker Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Content by Rob Coker:

 Discovery & Development Drug Discovery

Eli Lilly and Purdue Expand Partnership with $250 Million Investment

| Rob Coker | 2 min read

Eli Lilly and Purdue University strengthen their ongoing drug discovery collaboration with further initiatives.
Business & Regulation Bioprocessing - Upstream & Downstream

The Power List Personified: Getting to Know Beatrice Lavery

| Rob Coker | 4 min read

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.
Discovery & Development Analytical Science

Cracking the Code of Phages and How They Can Fight TB

| Rob Coker | 2 min read

How new structural insights captured in high-resolution images could fuel next-gen therapies for TB.
Business & Regulation Advanced Medicine

This Week’s Biopharma News: Long-Running CRISPR Patent Case Reopened

| Rob Coker | 4 min read

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity
Discovery & Development Technology and Equipment

Appreciating Academic Spinouts

| Rob Coker | 3 min read

Let us not forget the important role of academic spinouts in innovating across the modalities.
Discovery & Development Drug Discovery

AI and Synthetic Pharmacokinetics

| Rob Coker | 3 min read

Researchers use AI to produce synthetic pharmacokinetic data.
Business & Regulation Profession

Denmark and Sweden Invite Misplaced US Scientists to the EU

| Rob Coker | 2 min read

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.
Discovery & Development Advanced Medicine

Stem Cell Research and Treating Radiation Exposure

| Rob Coker | 3 min read

Researchers demonstrate how extracellular vesicles derived from mesenchymal stem cells can increase survival chances.
Business & Regulation Trends & Forecasts

Quality Over Quantity: EMA's New Approach to Biosimilars

| Rob Coker | 2 min read

EMA reflection paper considers elimination of routine comparative efficacy studies for biosimilars.
Business & Regulation Standards & Regulation

Trump's New Push on Drug Pricing

| Rob Coker | 2 min read

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker